Article 11Rabies
1.The multiannual programme for the eradication of rabies submitted by Italy is hereby approved for the period from 1 January 2011 to 31 December 2012.
2.The multiannual programme for the eradication of rabies submitted by Latvia is hereby approved for the period from 1 January 2011 to 31 December 2013.
3.The second year of the multiannual programmes for the eradication of rabies submitted by Lithuania and Austria are hereby approved for the period from 1 January 2011 to 31 December 2011.
4.The fourth year of the multiannual programme for the eradication of rabies submitted by Slovenia is hereby approved for the period from 1 January 2011 to 31 December 2011.
5.The financial contribution by the Union:
(a)shall include a lump sum of EUR 5 per wild animal sampled;
(b)shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of:
carrying out laboratory tests for the detection of rabies antigen or antibodies;
the isolation and characterisation of rabies virus;
the detection of biomarker and the titration of vaccine baits;
the purchase and distribution of oral vaccine plus baits;
the purchase and administration to livestock of parenteral vaccines; and
(c)shall not exceed the following for the year 2011:
EUR 2 250 000 for Italy;
EUR 1 800 000 for Latvia;
EUR 2 700 000 for Lithuania;
EUR 200 000 for Austria;
EUR 740 000 for Slovenia.
6.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:
:
EUR 12 per test;
:
EUR 12 per test;
:
EUR 18 per test;
:
EUR 0,60 per dose;
:
EUR 0,35 per dose;
:
EUR 1 per dose;
:
EUR 1,50 per animal vaccinated, regardless of the number of doses used.
7.Notwithstanding paragraphs 5 and 6, for the part of the Lithuanian multiannual programme that will be implemented outside its territory, the financial contribution by the Union shall:
(a)be granted only for the costs for the purchase and the distribution of oral vaccine plus baits;
(b)be at the rate of 100 %; and
(c)not exceed EUR 1 100 000 for the year 2011.
8.The maximum of the costs to be reimbursed for the costs referred to in paragraph 7 shall on average not exceed:
:
EUR 0,60 per dose;
:
EUR 0,35 per dose.